These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35751775)

  • 21. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
    Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
    Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment.
    Fernández-Díaz CM; Escobar-Curbelo L; López-Acosta JF; Lobatón CD; Moreno A; Sanz-Ortega J; Perdomo G; Cózar-Castellano I
    Histol Histopathol; 2018 Nov; 33(11):1167-1180. PubMed ID: 29726577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus.
    Inoue Y; Masuda T; Misumi Y; Ando Y; Ueda M
    Neurosci Lett; 2021 Sep; 762():136136. PubMed ID: 34311050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
    Haque R; Nazir A
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
    Tundo GR; Sbardella D; Ciaccio C; Grasso G; Gioia M; Coletta A; Polticelli F; Di Pierro D; Milardi D; Van Endert P; Marini S; Coletta M
    Crit Rev Biochem Mol Biol; 2017 Oct; 52(5):554-582. PubMed ID: 28635330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between insulin-degrading enzyme versus total tau and selected cytokines in patients with Alzheimer´s disease compared to non-demented controls.
    Kullenberg H; Nyström T; Kumlin M; Svedberg MM
    Neuro Endocrinol Lett; 2023 Jul; 44(4):199-205. PubMed ID: 37466059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin deprivation decreases insulin degrading enzyme levels in primary cultured cortical neurons and in the cerebral cortex of rats with streptozotocin-induced diabetes.
    Kazkayasi I; Burul-Bozkurt N; Ismail MA; Merino-Serrais P; Pekiner C; Cedazo-Minguez A; Uma S
    Pharmacol Rep; 2018 Aug; 70(4):677-683. PubMed ID: 29940507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
    Zhang H; Liu D; Huang H; Zhao Y; Zhou H
    Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
    Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
    Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
    Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
    J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
    Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
    PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families.
    Kim M; Hersh LB; Leissring MA; Ingelsson M; Matsui T; Farris W; Lu A; Hyman BT; Selkoe DJ; Bertram L; Tanzi RE
    J Biol Chem; 2007 Mar; 282(11):7825-32. PubMed ID: 17244626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
    Ivancic VA; Krasinski CA; Zheng Q; Meservier RJ; Spratt DE; Lazo ND
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
    Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
    J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Strategies for Alzheimer's Disease in the View of Diabetes Mellitus.
    Ohyagi Y; Miyoshi K; Nakamura N
    Adv Exp Med Biol; 2019; 1128():227-248. PubMed ID: 31062332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional characterization of pathogenic non- synonymous genetic mutations of human insulin-degrading enzyme by in silico methods.
    Shaik NA; Kaleemuddin M; Banaganapalli B; Khan F; Shaik NS; Ajabnoor G; Al-Harthi SE; Bondagji N; Al-Aama JY; Elango R
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):517-32. PubMed ID: 24059301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
    Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
    Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice.
    Merino B; Fernández-Díaz CM; Parrado-Fernández C; González-Casimiro CM; Postigo-Casado T; Lobatón CD; Leissring MA; Cózar-Castellano I; Perdomo G
    Metabolism; 2020 Dec; 113():154352. PubMed ID: 32916153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.